SPRY News

ARS PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ARS Pharmaceuticals and Encourages Investors to Contact the Firm

Join Class Action to Recover Losses from ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky Before October 5, 2026

SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Securities Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Represents Shareholders

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in ARS Pharmaceuticals Inc. Lawsuit - SPRY

Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. (SPRY) Investors - Lead Plaintiff Deadline on October 5, 2026

Pomerantz LLP Highlights Class Action Against ARS Pharmaceuticals, Inc. – SPRY

ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY

SPRY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!